Honduras Sessions 2020

XLI SOLACI Regional Sessions 15° Central América & the Caribbean Region.

June 24th & 25th, 2020.


Due to the world health crisis of COVID-19, this year we held the Honduras Sessions 2020 through the Zoom Plataform. 

Rewatch both webinars of the Honduras Sessions 2020 on our Youtube account.

Day 1 | Doctors – Coronary Interventionis in LATAM 2020: An Unexpected Challenge

 

Day 2 | NURSES AND TECHNICIANS – Selected Topics in the Cath Lab

 

Jornadas Virtuales Honduras - 25/06 - Tópicos en la Sala de Hemodinamia

More articles by this author

Peru Sessions 2023

Held on November 16 and 17, 2023 in the Good Hope Clinic Auditorium, Lima, Peru! The XLVII SOLACI 2023 Regional Sessions (16th Andean Region) was...

Colombia Sessions 2022

XLV SOLACI Regional Sessions– 15° Andean Region. October 6, 7 & 8, 2022 The XLV SOLACI Regional Sessions (15th Andean Region) were held on October 6,...

Paraguay 2022 Sessions

44th SOLACI Regional Sessions - 15th Southern Cone Regional Meeting June 30th - July 1st The 44th SOLACI Regional Sessions (15th Region Southern Cone) took place...

Mexico Sessions 2021

The XLIV SOLACI Mexico Sessions 2021 were held on December 9, 2021 within the framework of the SOCIME 2021 Congress. The activity consisted of a...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...